New scan spots hidden heart disease in gene carriers before symptoms start
NCT ID NCT07591038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a new radioactive dye can detect early signs of a heart condition called amyloidosis in people who carry a TTR gene mutation but have no heart failure symptoms. About 80 adults aged 30-80 will receive an injection of the dye and then have a PET/CT scan to look for amyloid buildup in the heart. The goal is to find disease earlier so treatment can begin sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75248, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A carpal tunnel clue to a silent heart threat?
- Implanted sensors may foresee heart failure crises
- Can a Gene-Silencing drug tame a rare heart disease?
- AI-Powered heart scans aim to predict deadly complications in muscular dystrophy
- New MRI scan could spot heart problems earlier
- Could your genes predict heart damage from irregular heartbeat?